Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015', http://bit.ly/29QFXPp


In this issue


Home Eurosurveillance Edition  2015: Volume 20/ Issue 46 Article 5
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 20, Issue 46, 19 November 2015
News
Eurosurveillance editorial team: ECDC publishes 2014 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe

+ Author affiliations


Citation style for this article: Eurosurveillance editorial team. ECDC publishes 2014 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe. Euro Surveill. 2015;20(46):pii=30068. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2015.20.46.30068

Received:19 November 2015; Accepted:19 November 2015

In relation to the 8th European Antibiotic Awareness Day on 18 November, the European Centre for Disease Prevention and Control (ECDC) has published the annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) [1]. On the same occasion, an update with 2014 data of the EARS-Net interactive database on antimicrobial resistance [2] and the European Surveillance of Antimicrobial Consumption Network (ESAC-Net) interactive database on antimicrobial consumption [3] was released, on the ECDC website.

The data on antimicrobial resistance showed that the percentages of Klebsiella pneumoniae isolates resistant to fluoroquinolones, third-generation cephalosporins and aminoglycosides, as well as combined resistance to all three antibiotic groups increased significantly at European Union (EU)/European Economic Area (EEA) level over the last four years. A significant increase was also observed for carbapenem resistance in K. pneumoniae.

For Escherichia coli, resistance to third-generation cephalosporins and combined resistance to fluoroquinolones, third-generation cephalosporins and aminoglycosides increased significantly at EU/EEA level. The increase in combined resistance, and the increase in resistance to last line groups of antimicrobials such as the carbapenems, is a serious cause for concern and a threat to patient safety in Europe.

Data on antimicrobial consumption in 2014 show that the overall consumption of antimicrobials in the community in the EU/EEA was 21.6 defined daily doses (DDD) per 1,000 inhabitants and per day. The large inter-country variation in antibiotic consumption observed in previous years remained. When antibiotic consumption was expressed in terms of number of packages (a better estimate for prescriptions) per 1,000 inhabitants and per day, five countries (Denmark, Luxembourg, Slovenia, Spain and Sweden) showed a significant decrease during 2010–2014.

During the same period, antibiotic consumption in the hospital sector (expressed in DDD per 1,000 inhabitants and per day) showed a significant increasing trend. A significant increase in the consumption of specific antibiotic groups, e.g. carbapenems, was also observed during this period at EU/EEA level, and in several countries. Although the vast majority of antibiotics is consumed in the community, i.e. outside hospitals, antibiotic consumption in hospitals is a major driver of the spread of multidrug-resistant bacteria responsible for healthcare-associated infections.



References

  1. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2015. Available from http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-europe-2014.pdf

  2. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance interactive database (EARS-Net). Stockholm: ECDC. [Accessed 19 Nov 2015]. Available from http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx

  3. European Centre for Disease Prevention and Control (ECDC). The European Surveillance of Antimicrobial Consumption Network interactive database on antimicrobial consumption (ESAC-Net). Stockholm: ECDC. [Accessed 19 Nov 2015]. Available from http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/esac-net-database/Pages/database.aspx



Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.